Octave Specialty Group is expected to report second-quarter 2026 results on August 6 after the closing bell, with the Zacks Consensus Estimate for revenues pegged at $81 million, indicating 47.4% growth from the year-ago figure. The consensus estimate for the bottom line is a loss of 1 cent per share, a year-over-year improvement of 95.5%. The company has beaten estimates in the trailing four quarters with an average surprise of 464.4%, but the Zacks model does not predict a beat this time as its Earnings ESP is 0.00% and it carries a Zacks Rank of 3. Revenue growth is likely driven by higher net premiums earned, commissions, and servicing fees, while net investment income may have declined due to lower yields on corporate short-term investments.
Octave Specialty Group, Inc.Expected revenue growth and narrower loss in Q2
Oscar Health Inc
MetLife Inc
Prudential Financial, Inc.